Ignite Creation Date:
2025-12-24 @ 5:38 PM
Ignite Modification Date:
2026-01-24 @ 5:48 AM
Study NCT ID:
NCT01665768
Status:
COMPLETED
Last Update Posted:
2021-10-26
First Post:
2012-07-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-09
Start Date Type:
ACTUAL
Primary Completion Date:
2017-10
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-08
Completion Date Type:
ACTUAL
First Submit Date:
2012-07-27
First Submit QC Date:
None
Study First Post Date:
2012-08-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-11-09
Results First Submit QC Date:
None
Results First Post Date:
2018-12-26
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-04
Last Update Post Date:
2021-10-26
Last Update Post Date Type:
ACTUAL